Health News Channel

Journalists Unpack Patchwork Vaccine Rollout Rapid Covid Tests and More

KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

Simulations reveal how dominant SARS-CoV-2 strain binds to host succumbs to antibodies

The dominant G-form spike protein 'puts its head up' more frequently to latch on to receptors, but that makes it more vulnerable to neutralization.

Neural plasticity depends on this long noncoding RNAs journey from nucleus to synapse

A synaptically localized long noncoding RNA proves to be an important regulator of neural plasticity.

COVID-19 Scientists identify human genes that fight infection

Scientists have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers' understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body's frontline virus fighters.

Female protective effect Researchers find clues to sex differences in autism

Researchers have found that autism may develop in different regions of the brain in girls than boys and that girls with autism have a larger number of genetic mutations than boys, suggesting that they require a larger 'genetic hit' to develop the disorder.

New CRISPR technology offers unrivaled control of epigenetic inheritance

Scientists have figured out how to modify CRISPR's basic architecture to extend its reach beyond the genome and into what's known as the epigenome -- proteins and small molecules that latch onto DNA and control when and where genes are switched on or off.

Study shows past COVID-19 infection doesnt fully protect young people against reinfection

Results of a new study suggest vaccination against COVID-19 remains crucial even in young adults who were previously infected.

Experimental antiviral for COVID-19 effective in hamster study

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study. MK-4482, delivered orally, is now in human clinical trials.

Sidebar

Health Information